Site search
2877 results for '' found
Wellness_Centre_Newsletter_March_2026.pdf
Referral_for_Admission_to_Alfred_PARC.pdf
WITHDRAWal of heart failure directed therapies in recovered Atrial Fibrillation mediated cardiomyopathy long term follow-up study- the WITHDRAW-AF long term follow-up study (Trial Not Registered)
WITHDRAWal of heart failure directed therapies in recovered Atrial Fibrillation mediated cardiomyopathy long term follow-up study- the WITHDRAW-AF long term follow-up study (Trial Not Registered)
/
A Phase 3 Randomized Study Comparing JNJ-79635322 and an Anti-BCMAxCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma who Have Received at Least 3 Prior Lines of
A Phase 3 Randomized Study Comparing JNJ-79635322 and an Anti-BCMAxCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma who Have Received at Least 3 Prior Lines of
/
The Alfred Interventional Radiology Thyroid Ablation Study (Trial Not Registered)
The Alfred Interventional Radiology Thyroid Ablation Study (Trial Not Registered)
/
Prospective Interventional Study of Effectiveness of Efanesoctocog Alfa Prophylaxis on Synovial Hypertrophy in Patients with Hemophilia A (NCT06941870)
Prospective Interventional Study of Effectiveness of Efanesoctocog Alfa Prophylaxis on Synovial Hypertrophy in Patients with Hemophilia A (NCT06941870)
/
Prophylaxis against early ventilator-associated infections to reduce mortality in mechanically ventilated ICU patients with acute brain injuries (NCT06819592)
Prophylaxis against early ventilator-associated infections to reduce mortality in mechanically ventilated ICU patients with acute brain injuries (NCT06819592)
/
Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated with Pirtobrutinib after Previous Treatment with Zanubrutinib (NCT06812715)
Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated with Pirtobrutinib after Previous Treatment with Zanubrutinib (NCT06812715)
/
PACEmaker AUGMENTed AF ablation in participants with AF and sinus node disease – the PACE AUGMENT-AF Study (ACTRN12625000546459)
PACEmaker AUGMENTed AF ablation in participants with AF and sinus node disease – the PACE AUGMENT-AF Study (ACTRN12625000546459)
/
A Phase 1 Study to Evaluate the Safety of a Novel, In Vivo Gene Therapy to Create Anti-BCMA CAR-T Cells in Patients with Relapsed and Refractory Multiple Myeloma (NCT07075185)
A Phase 1 Study to Evaluate the Safety of a Novel, In Vivo Gene Therapy to Create Anti-BCMA CAR-T Cells in Patients with Relapsed and Refractory Multiple Myeloma (NCT07075185)
/